by maheshbhuva | Jul 6, 2026 | Analytical Chemistry, Newsletter
Introduction A pharmacopoeia update plays an important role in the pharmaceutical industry. New standards are released regularly to improve the quality, safety, and effectiveness of medicines. These updates should be reviewed carefully by pharmaceutical manufacturers,...
by maheshbhuva | Jun 3, 2026 | Analytical Chemistry, Newsletter
🇺🇸 FDA Updates CAVHANZA (nilotinib) approved (June 2, 2026) for Ph+ chronic myeloid leukemia with improved formulation allowing use alongside PPIs/H2 blockers without restrictions. Ensitrelvir (Xocova) approved (May 29, 2026) as the first oral option for COVID-19...
